Neon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch NTGN and buy or sell other stocks, ETFs, and their options commission-free!

About NTGN

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. 

CEO
Hugh O'Dowd, MBA
CEOHugh O'Dowd, MBA
Employees
Employees
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
Employees

NTGN Key Statistics

Market cap
88.93M
Market cap88.93M
Price-Earnings ratio
-1.14
Price-Earnings ratio-1.14
Dividend yield
Dividend yield
Average volume
665.16K
Average volume665.16K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$5.97
52 Week high$5.97
52 Week low
$0.88
52 Week low$0.88

Stock Snapshot

As of today, Neon Therapeutics(NTGN) shares are valued at $3.07. The company's market cap stands at 88.93M, with a P/E ratio of -1.14.

On 2026-03-14, Neon Therapeutics(NTGN) shares started trading at —, with intraday highs of — and lows of —.

Trading volume for Neon Therapeutics(NTGN) stock has reached 0, versus its average volume of 665.16K.

The stock's 52-week range extends from a low of $0.88 to a high of $5.97.

The stock's 52-week range extends from a low of $0.88 to a high of $5.97.

People also own

Based on the portfolios of people who own NTGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.